| Literature DB >> 31745108 |
Ji Cheol Shin1, Eun Young Han2, Kye Hee Cho3, Sang Hee Im4.
Abstract
Cervical and upper thoracic spinal cord injury causes impairments in respiratory muscle performance, leading to variable degrees of pulmonary dysfunction and rendering deep breathing difficult for affected individuals. In this retrospective study, we investigated the effects of self-directed respiratory muscle training in this context by assessing pulmonary function relative to spinal cord injury characteristics. A total of 104 spinal cord injury patients (tetraplegia/paraplegia; 65/39, acute/subacute/chronic; 14/42/48) were admitted for short-term (4-8 weeks) in-patient clinical rehabilitation. Initial evaluation revealed a compromised pulmonary function with a percentage of predicted value of 62.0 and 57.5 in forced vital capacity in supine and forced vital capacity in sitting positions, respectively. Tetraplegic patients had more compromised pulmonary function compared with paraplegic patients. At follow-up evaluation, the percentage of predicted value of forced vital capacity in supine and sitting position improved overall on average by 11.7% and 12.7%, respectively. The peak cough flow improved by 22.7%. All assessed pulmonary function parameters improved significantly in all subgroups, with the greatest improvements found in patients with tetraplegia and subacute spinal cord injury. Therefore, short-term self-directed respiratory muscle training should be incorporated into all spinal cord injury rehabilitation regimens, especially for patients with tetraplegia and subacute spinal cord injury, as well as those with chronic spinal cord injury.Entities:
Mesh:
Year: 2019 PMID: 31745108 PMCID: PMC6863911 DOI: 10.1038/s41598-019-52526-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographics and clinical characteristics.
| Characteristics (%) | N = 104 |
|---|---|
| Age (years, range) | 48.7 ± 17.5 (15–84) |
| Male/female | 78/26 (75.0/25.0) |
| Trauma | 94 (90.4) |
| Vascular | 4 (3.8) |
| Tumour | 3 (2.9) |
| Infection | 3 (2.9) |
| Tetraplegia/paraplegia | 65/39 (62.5/37.5) |
| AIS A/B/C/D | 21/7/30/46 (20.2/6.7/28.8/44.2) |
| Complete/Incomplete | 21/83 (20.2/79.8) |
| Disease duration (day, range) | 97.4 ± 139.2 (7–993) |
| 14/42/48 (13.5/40.4/46.2) | |
| Acute (tetraplegia/paraplegia) | 9/5 (64.3/35.7) |
| Subacute (tetraplegia/paraplegia) | 30/15 (66.7/33.3) |
| Chronic (tetraplegia/paraplegia) | 26/19 (57.8/42.2) |
| Height (cm, range) | 168.3 ± 8.8 (129–186) |
| Body weight (kg, range) | 64.6 ± 11.4 (24–95) |
| Body mass index (kg/m2, range) | 22.7 ± 3.2 (13.9–33.4) |
Values are mean ± standard deviation. (% or range).
AIS, ASIA Impairment Scale.
Change in forced vital capacity in the supine position before and after short-term rehabilitation according to the level of injury, injury severity, and disease duration.
| (N) | FVCsup (mL) | pre%FVCsup (%) | ||||||
|---|---|---|---|---|---|---|---|---|
| Initial | Follow up | Δ (%) | Initial | Follow up | Δ | |||
| Intra group | Inter group | |||||||
| Total (104) | 2673.0 ± 879.8 | 3209.0 ± 883.0 | 536.1 ± 491.0 (24.3) | <0.001** | 62.0 ± 18.9 | 74.3 ± 17.8 | 12.3 ± 10.6 | |
| Tetraplegia (65) | 2474.9 ± 758.7 | 3112.3 ± 860.5 | 637.4 ± ± 518.80 (29.3) | <0.001** | 0.003†† | 57.5 ± 16.9 | 72.1 ± 18.2 | 14.6 ± 10.9 |
| Paraplegia (39) | 3003.1 ± 974.5 | 3370.3 ± ± 907.6 | 367.2 ± 391.4 (16.0) | <0.001** | 69.5 ± 19.8 | 78.0 ± 16.8 | 8.5 ± 9.1 | |
| Complete (21) | 2649.1 ± 1024.0 | 3018.1 ± 1037.0 | 369.1 ± 369.3 (18.2) | <0.001** | 0.039* | 56.2 ± 19.5 | 64.3 ± 19.7 | 8.1 ± 7.9 |
| Incomplete (83) | 2679.0 ± 846.4 | 3257.4 ± 839.9 | 578.3 ± 510.4 (25.9) | <0.001** | 63.5 ± 18.5 | 76.9 ± 16.5 | 13.4 ± 11.0 | |
| Acute (14) | 2705.0 ± 964.1 | 3095.7 ± 1081.5 | 390.7 ± 433.2 (15.7) | <0.001** | 0.002†† | 65.7 ± 21.2 | 73.4 ± 22.9 | 9.6 ± 9.8 |
| Subacute (45) | 2634.9 ± 944.8 | 3365.3 ± 877.0 | 730.4 ± 485.8 (33.8) | <0.001** | 53.7 ± 20.4 | 71.0 ± 17.6 | 16.3 ± 10.2 | |
| Chronic (45) | 2701.1 ± 801.3 | 3088.0 ± 816.3 | 386.9 ± 454.4 (17.6) | <0.001** | 58.8 ± 19.4 | 68.4 ± 19.7 | 9.1 ± 10.1 | |
Values are mean ± standard deviation.
**p < 0.01 by paired t test, ††p < 0.01 by Wilcoxon test.
FVC, forced vital capacity; FVCsup, FVC in supine position; pre%, percentage of the predicted normal value; Δ, change.
Change in forced vital capacity in the sitting position before and after short-term rehabilitation according to the level of injury, injury severity, and disease duration.
| (N) | FVCsup (mL) | pre%FVCsup (%) | ||||||
|---|---|---|---|---|---|---|---|---|
| Initial | Follow up | Δ (%) | Initial | Follow up | Δ | |||
| Intra group | Inter group | |||||||
| Total (104) | 2468.9 ± 922.2 | 3028.9 ± 930.8 | 560.0 ± 507.5 (28.9) | <0.001** | 57.5 ± 20.3 | 70.2 ± 19.2 | 12.3 ± 10.6 | |
| Tetraplegia (65) | 2226.5 ± 784.1 | 2888.5 ± 887.1 | 662.0 ± 537.5 (36.0) | <0.001** | 0.004†† | 52.1 ± 18.2 | 67.1 ± 19. | 15.0 ± 11.3 |
| Paraplegia (39) | 2872.8 ± 1000.9 | 3262.8 ± 965.8 | 390.0 ± 405.1 (17.2) | <0.001** | 66.5 ± 20.2 | 75.4 ± 18.1 | 8.9 ± 9.4 | |
| Complete (21) | 2429.5 ± 1003.1 | 2844.8 ± 1021.2 | 415.2 ± 359.5 (20.5) | <0.001** | 0.072 | 51.6 ± 19.4 | 60.5 ± 19.6 | 8.9 ± 7.4 |
| Incomplete (83) | 2478.8 ± 906.8 | 3075.4 ± 907.2 | 596.6 ± 534.1 (31.1) | <0.001** | 59.0 ± 20.3 | 72.6 ± 18.4 | 13.7 ± 11.5 | |
| Acute (14) | 2687.1 ± 1017.8 | 3005.7 ± 1139.4 | 318.6 ± 434.8 (12.9) | <0.001** | 0.002†† | 65.7 ± 21.2 | 73.4 ± 22.9 | 7.7 ± 9.1 |
| Subacute (45) | 2385.1 ± 999.1 | 3165.8 ± 940.1 | 780.7 ± 503.3 (42.3) | <0.001** | 53.7 ± 20.4 | 71.0 ± 17.6 | 17.4 ± 10.4 | |
| Chronic (45) | 2484.7 ± 814.8 | 2899.1 ± 851.0 | 414.4 ± 451.5 (20.6) | <0.001** | 58.8 ± 19.4 | 68.4 ± 19.7 | 9.6 ± 10.4 | |
Values are mean ± standard deviation.
**p < 0.01 by paired t test, ††p < 0.01 by Wilcoxon test.
FVC, forced vital capacity; FVCsit, FVC in sitting position; pre%, percentage of the predicted normal value; Δ, change.
Change in peak cough flow before and after short-term rehabilitation according to the level of injury, injury severity, and disease duration.
| (N) | FVCsup (mL) | ||||
|---|---|---|---|---|---|
| Initial | Follow up | Δ (%) | |||
| Intra group | Inter group | ||||
| Total (104) | 300.2 ± 145.4 | 385.6 ± 145.7 | 85.4 ± 82.9 (63.4) | <0.001** | |
| Tetraplegia (65) | 266.9 ± 136.8 | 355.2 ± 137.5 | 88.3 ± 78.9 (82.1) | <0.001** | 0.003†† |
| Paraplegia (39) | 355.8 ± 144.0 | 436.2 ± 146.7 | 80.4 ± 90.0 (32.1) | <0.001** | |
| Complete (21) | 285.7 ± 140.0 | 366.7 ± 150.2 | 81.0 ± 69.0 (35.7) | <0.001** | 0.653 |
| Incomplete (83) | 303.9 ± 147.4 | 390.4 ± 145.1 | 86.5 ± 86.4 (70.4) | <0.001** | |
| Acute (14) | 347.1 ± 136.1 | 388.6 ± 136.0 | 41.4 ± 53.9 (14.9) | <0.001** | 0.004†† |
| Subacute (45) | 284.6 ± 150.0 | 398.0 ± 157.8 | 113.4 ± 94.8 (104.8) | <0.001** | |
| Chronic (45) | 301.3 ± 143.4 | 372.3 ± 137.9 | 70.9 ± 67.9 (37.0) | <0.001** | |
Values are mean ± standard deviation.
**p < 0.01 by paired t test, ††p < 0.01 by Wilcoxon test.
PCF, peak cough flow; %ΔPCF, percent change of peak cough flow; L/min, litre per minute.
Figure 1Inter- and intra-group comparisons of forced vital capacity (FVC) and peak cough flow (PCF) before and after short-term rehabilitation according to the level of injury, injury severity, and disease duration. *P < 0.05, **P < 0.01.
Comparison between forced vital capacity in the supine position and forced vital capacity in the sitting position before and after short-term rehabilitation according to the level of injury, injury severity, and disease duration.
| (N) | Initial | Follow up | ||||
|---|---|---|---|---|---|---|
| FVCsup (mL) | FVCsit (mL) | FVCsup (mL) | FVCsit (mL) | |||
| Total (104) | 2673.0 ± 879.8 | 2468.9 ± 922.2 | <0.001** | 3209.0 ± 883.0 | 3028.9 ± 930.8 | <0.001** |
| Tetraplegia (65) | 2474.9 ± 758.7 | 2226.5 ± 784.1 | <0.001** | 3112.3 ± 860.5 | 2888.5 ± 887.1 | 0.001** |
| Paraplegia (39) | 3003.1 ± 974.5 | 2872.8 ± 1000.9 | 0.001** | 3370.3 ± 907.6 | 3262.8 ± 965.8 | 0.002** |
| Complete (21) | 2649.1 ± 1024.0 | 2429.5 ± 1003.1 | <0.001** | 3018.1 ± 1037.0 | 2844.8 ± 1021.2 | <0.001** |
| Incomplete (83) | 2679.0 ± 846.4 | 2478.8 ± 906.8 | 0.011* | 3257.4 ± 839.9 | 3075.4 ± 907.2 | <0.001** |
| Acute (14) | 2705.0 ± 964.1 | 2687.1 ± 1017.8 | 0.747 | 3095.7 ± 1081.5 | 3005.7 ± 1139.4 | 0.119 |
| Subacute (45) | 2634.9 ± 944.8 | 2385.1 ± 999.1 | <0.001** | 3365.3 ± 877.0 | 3165.8 ± 940.1 | <0.001** |
| Chronic (45) | 2701.1 ± 801.3 | 2484.7 ± 814.8 | <0.001** | 3088.0 ± 816.3 | 2899.1 ± 851.0 | <0.001** |
Values are mean ± standard deviation.
*p < 0.05, **p < 0.01 by paired t test.
FVC, forced vital capacity; FVCsup, FVC in supine position; FVCsit, FVC in sitting position.
Figure 2Comparisons of changes in each parameters of pulmonary function before and after short-term rehabilitation according to the disease duration. *P < 0.05, ANOVA with Bonferroni post-hoc test. FVC, forced vital capacity; FVCsup, FVC in supine position; FVCsit, FVC in sitting position; Δ, change.
Correlation between the initial pulmonary function and the percent improvement of pulmonary function.
| Initial FVCsup | Initial FVCsit | Initial PCF | %ΔFVCsup | %Δ FVCsit | %ΔPCF | |
|---|---|---|---|---|---|---|
| %ΔFVCsup | −0.531** | −0.510** | −0.428** | 1 | 0.795** | 0.499** |
| %ΔFVCsit | −0.386** | −0.513** | −0.414** | 0.795** | 1 | 0.550** |
| %ΔPCF | −0.209* | −0.248* | −0.328** | 0.499** | 0.550** | 1 |
Values are Pearson correlation coefficient r.
*P < 0.05, **P < 0.01.
FVC, forced vital capacity; FVCsup, FVC in supine position; FVCsit, FVC in sitting position; Δ, change.